302 related articles for article (PubMed ID: 10777217)
1. Tumor-derived mutations within the DNA-binding domain of p53 that phenotypically resemble the deletion of the proline-rich domain.
Roth J; Koch P; Contente A; Dobbelstein M
Oncogene; 2000 Mar; 19(14):1834-42. PubMed ID: 10777217
[TBL] [Abstract][Full Text] [Related]
2. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression.
Venot C; Maratrat M; Dureuil C; Conseiller E; Bracco L; Debussche L
EMBO J; 1998 Aug; 17(16):4668-79. PubMed ID: 9707426
[TBL] [Abstract][Full Text] [Related]
3. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
4. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
Seoane J; Le HV; Massagué J
Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity.
Zhu J; Jiang J; Zhou W; Zhu K; Chen X
Oncogene; 1999 Mar; 18(12):2149-55. PubMed ID: 10321740
[TBL] [Abstract][Full Text] [Related]
6. Constitutive and DNA damage inducible activation of pig3 and MDM2 genes by tumor-derived p53 mutant C277Y.
Pospísilová S; Siligan C; Ban J; Jug G; Kovar H
Mol Cancer Res; 2004 May; 2(5):296-304. PubMed ID: 15192123
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
Das S; El-Deiry WS; Somasundaram K
J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
[TBL] [Abstract][Full Text] [Related]
8. SSRP1 functions as a co-activator of the transcriptional activator p63.
Zeng SX; Dai MS; Keller DM; Lu H
EMBO J; 2002 Oct; 21(20):5487-97. PubMed ID: 12374749
[TBL] [Abstract][Full Text] [Related]
9. p21/CDKN1A mediates negative regulation of transcription by p53.
Löhr K; Möritz C; Contente A; Dobbelstein M
J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
[TBL] [Abstract][Full Text] [Related]
10. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
[TBL] [Abstract][Full Text] [Related]
11. How many mutant p53 molecules are needed to inactivate a tetramer?
Chan WM; Siu WY; Lau A; Poon RY
Mol Cell Biol; 2004 Apr; 24(8):3536-51. PubMed ID: 15060172
[TBL] [Abstract][Full Text] [Related]
12. ING1 represses transcription by direct DNA binding and through effects on p53.
Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
[TBL] [Abstract][Full Text] [Related]
13. Rescue of mutant p53 transcription function by ellipticine.
Peng Y; Li C; Chen L; Sebti S; Chen J
Oncogene; 2003 Jul; 22(29):4478-87. PubMed ID: 12881704
[TBL] [Abstract][Full Text] [Related]
14. Binding to the naturally occurring double p53 binding site of the Mdm2 promoter alleviates the requirement for p53 C-terminal activation.
Kaku S; Iwahashi Y; Kuraishi A; Albor A; Yamagishi T; Nakaike S; Kulesz-Martin M
Nucleic Acids Res; 2001 May; 29(9):1989-93. PubMed ID: 11328884
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of differential activation of target gene promoters by p53 hinge domain mutants with impaired apoptotic function.
Kong XT; Gao H; Stanbridge EJ
J Biol Chem; 2001 Aug; 276(35):32990-3000. PubMed ID: 11395510
[TBL] [Abstract][Full Text] [Related]
16. p73 can suppress the proliferation of cells that express mutant p53.
Willis AC; Pipes T; Zhu J; Chen X
Oncogene; 2003 Aug; 22(35):5481-95. PubMed ID: 12934108
[TBL] [Abstract][Full Text] [Related]
17. The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Baptiste N; Friedlander P; Chen X; Prives C
Oncogene; 2002 Jan; 21(1):9-21. PubMed ID: 11791172
[TBL] [Abstract][Full Text] [Related]
18. Increased apoptosis induction by 121F mutant p53.
Saller E; Tom E; Brunori M; Otter M; Estreicher A; Mack DH; Iggo R
EMBO J; 1999 Aug; 18(16):4424-37. PubMed ID: 10449408
[TBL] [Abstract][Full Text] [Related]
19. Deletion of the COOH-terminal region of p73alpha enhances both its transactivation function and DNA-binding activity but inhibits induction of apoptosis in mammalian cells.
Ozaki T; Naka M; Takada N; Tada M; Sakiyama S; Nakagawara A
Cancer Res; 1999 Dec; 59(23):5902-7. PubMed ID: 10606232
[TBL] [Abstract][Full Text] [Related]
20. The proline-rich region of mouse p53 influences transactivation and apoptosis but is largely dispensable for these functions.
Edwards SJ; Hananeia L; Eccles MR; Zhang YF; Braithwaite AW
Oncogene; 2003 Jul; 22(29):4517-23. PubMed ID: 12881708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]